Primary Site >> Stomach Cancer
Gene >> PLAUR
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. PMID: 7636552 |
Ref: Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues. PMID: 8703368 |
Ref: Immunocytochemical phenotyping of disseminated tumor cells in bone marrow by uPA receptor and CK18: investigation of sensitivity and specificity of an immunogold/alkaline phosphatase double staining protocol. PMID: 9016310 Ref: Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role. PMID: 9219730 Ref: Correlation between expression of urokinase-type plasminogen activator receptor and metastasis in gastric carcinoma. PMID: 21590227 |
Ref: Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns. PMID: 9502078 Ref: The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor. PMID: 9610690 Ref: Expression of urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in gastric cancer. PMID: 9794194 Ref: Urokinase receptor antagonists: novel agents for the treatment of cancer. PMID: 15991980 |
Ref: Differing expression of MMPs-1 and -9 and urokinase receptor between diffuse- and intestinal-type gastric carcinoma. PMID: 9988236 Ref: CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopy. PMID: 10493940 |
Ref: Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines. PMID: 11029504 |
Ref: Overexpression of urokinase-type plasminogen activator in human gastric cancer cell line (AGS) induces tumorigenicity in severe combined immunodeficient mice. PMID: 11856478 |
Ref: Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer. PMID: 12708473 Ref: Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. PMID: 12907645 Ref: Overexpression of c-met Protein in Gastric Cancer and Role of uPAR as a Therapeutic Target. PMID: 26680909 |
Ref: Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer. PMID: 15218312 |
Ref: Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells. PMID: 15870884 Ref: Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. PMID: 16109653 |
Ref: Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer. PMID: 16646560 Ref: Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer. PMID: 16810742 |
Ref: Helicobacter pylori stimulates urokinase plasminogen activator receptor expression and cell invasiveness through reactive oxygen species and NF-kappaB signaling in human gastric carcinoma cells. PMID: 17334646 Ref: Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion. PMID: 17335808 Ref: Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells. PMID: 17970088 |
Ref: Inhibition of tumor growth and metastasis by ATF-Fc, an engineered antibody targeting urokinase receptor. PMID: 18245952 Ref: Lysophosphatidic acid promotes cell invasion by up-regulating the urokinase-type plasminogen activator receptor in human gastric cancer cells. PMID: 18247343 Ref: The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells. PMID: 18466392 Ref: Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells. PMID: 18599586 Ref: EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells. PMID: 19020743 |
Ref: Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases. PMID: 19050704 |
Ref: MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF-kappaB signals in gastric cancer cells. PMID: 21081472 Ref: 17beta-estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice. PMID: 21680705 |
Ref: A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. PMID: 21500189 Ref: Urokinase plasminogen activator receptor on invasive cancer cells: a prognostic factor in distal gastric adenocarcinoma. PMID: 21901747 Ref: Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting betacatenin signaling. PMID: 22710759 |
Ref: Somatostatin receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer. PMID: 23722468 Ref: Targeting of peptide conjugated magnetic nanoparticles to urokinase plasminogen activator receptor (uPAR) expressing cells. PMID: 23835641 Ref: IGFBP3, a transcriptional target of homeobox D10, is correlated with the prognosis of gastric cancer. PMID: 24386080 |
Ref: Cadmium induces urokinase-type plasminogen activator receptor expression and the cell invasiveness of human gastric cancer cells via the ERK-1/2, NF-kappaB, and AP-1 signaling pathways. PMID: 25069788 Ref: Soluble urokinase-type plasminogen activator receptor and ferritin concentration in patients with advanced alimentary tract carcinoma. Relationship to localization, surgical treatment and the stage of the disease--preliminary report. PMID: 25618124 |
Ref: Identification of potential targets for diallyl disulfide in human gastric cancer MGC-803 cells using proteomics approaches. PMID: 25812569 Ref: Prognostic role of urokinase plasminogen activator receptor in gastric and colorectal cancer: A systematic review and meta-analysis. PMID: 26150727 |
Ref: Effect of urokinase-type plasminogen activator system in gastric cancer with peritoneal metastasis. PMID: 27313768 |
Ref: Prostaglandin E2 stimulates urokinase-type plasminogen activator receptor via EP2 receptor-dependent signaling pathways in human AGS gastric cancer cells. PMID: 27377703 Ref: In vitro activity of probiotic Lactobacillus reuteri against gastric cancer progression by downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor gene expression. PMID: 28643742 Ref: EGF-induced urokinase plasminogen activator receptor promotes epithelial to mesenchymal transition in human gastric cancer cells. PMID: 28849196 Ref: MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer. PMID: 29075357 |
Ref: Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-kappab, PKC-delta, ERK1/2, and AMPKalpha. PMID: 28627240 Ref: [Effects of MTA1 on biological behaviors of gastric cancer cells]. PMID: 30139027 |